All lobbying filings

IONIS PHARMACEUTICALS, INC.

Lobbying for IONIS PHARMACEUTICALS, INC. · Biotechnology company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $140,000.00 expenses · posted Jan 18, 2026

Official filing document

Bills named in this filing 8

HR 1672
Maintaining Investments in New Innovation Act
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025
HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S 832
EPIC Act of 2025
HR 1414
Cameron’s Law

Lobbying activity 3

Health Issues

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act. Issues related drug pricing policy.

Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act. Issues related to the Medicaid rebate.

Taxation/Internal Revenue Code

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.